The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1344
ISSUE1344
Med Lett Drugs Ther. 2010 Aug 9;52(1344):64
Disclosures
Objective(s)
In issue 1343, the usual decrease in LDL-cholesterol with pitavastatin (Livalo) in the table on page 58 should have been 35-40% with 2 mg and 40-45% with 4 mg. Also, in the paragraph on Dosage and Administration, the definition of moderately decreased renal function should have been 30-<60 mL/min/1.73 m2.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article